Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
Short communication: Modulation of the small intestinal microbial community composition over short-term or long-term administration with Lactobacillus plantarum ZDY2013. β
Go to Publication β
Journal of dairy science (J Dairy Sci ) Vol: 99 Issue 9 Pages: 6913-6921 Pub: 2016 Sep Epub: 2016 Jun 16 Authors Xie Q , Pan M , Huang R , Tian X , Tao X , Shah NP , Wei H , Wan C , |
|
Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats. β
Go to Publication β
The British journal of nutrition (Br J Nutr ) Vol: 118 Issue 7 Pages: 481-492 Pub: 2017 Oct Epub: Authors Song JJ , Tian WJ , Kwok LY , Wang YL , Shang YN , Menghe B , Wang JG , |
|
Lactobacillus plantarum HNU082-derived improvements in the intestinal microbiome prevent the development of hyperlipidaemia. β
Go to Publication β
Food & function (Food Funct ) Vol: 8 Issue 12 Pages: 4508-4516 Pub: 2017 Dec 13 Epub: Authors Shao Y , Huo D , Peng Q , Pan Y , Jiang S , Liu B , Zhang J , |
|
Probiotic <i>Lactobacillus plantarum</i> Promotes Intestinal Barrier Function by Strengthening the Epithelium and Modulating Gut Microbiota. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 1953 Pub: 2018 Epub: 2018 Aug 24 Authors Wang J , Ji H , Wang S , Liu H , Zhang W , Zhang D , Wang Y , |
|
Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 254 Issue Pt 1 Pages: 127624 Pub: 2023 Oct 31 Epub: 2023 Oct 31 Authors Wang Q , Jiang B , Wei M , He Y , Wang Y , Zhang Q , Wei H , Tao X , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.